医学
肝细胞癌
内科学
胃肠病学
入射(几何)
队列
阿替唑单抗
贝伐单抗
累积发病率
肝癌
癌症
免疫疗法
肿瘤科
无容量
化疗
光学
物理
作者
Ciro Celsa,Giuseppe Cabibbo,Claudia Angela Maria Fulgenzi,Bernhard Scheiner,Antonio D’Alessio,Giulia Francesca Manfredi,Naoshi Nishida,Celina Ang,Thomas U. Marron,Anwaar Saeed,Brooke Wietharn,Matthias Pinter,Jaekyung Cheon,Yi‐Hsiang Huang,Pei‐Chang Lee,Samuel Phen,Anuhya Gampa,Anjana Pillai,Caterina Vivaldi,Francesca Salani
标识
DOI:10.1016/j.jhep.2023.10.040
摘要
Immune-related liver injury (irLI) is commonly observed in patients with cancer treated with immune checkpoint inhibitors (ICIs). We aimed to compare the incidence, clinical characteristics, and outcomes of irLI between patients receiving ICIs for hepatocellular carcinoma (HCC) vs. other solid tumours.
科研通智能强力驱动
Strongly Powered by AbleSci AI